Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Beimei Pharmaceutical is a China-based pharmaceutical company headquartered in the China Medical City, Taizhou. The company specializes in the research, development, manufacturing, and commercialization of pediatric medicines, with a strong focus on respiratory, anti-infective, and digestive therapeutic areas. Beimei is known for its expertise in developing high-barrier generic drugs and improved new formulations tailored for children, such as oral suspensions and chewable tablets. Their portfolio includes widely used treatments like Oseltamivir Phosphate and Montelukast Sodium. The company operates modern GMP-certified manufacturing facilities to support its domestic and international growth strategies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Beimei Pharmaceutical.